Related references
Note: Only part of the references are listed.Healing of non-displaced fractures produced by fatigue loading of the mouse ulna
Mario D. Martinez et al.
BONE (2010)
Temporal pattern of gene expression and histology of stress fracture healing
L. J. Kidd et al.
BONE (2010)
Atypical fractures of the femur and bisphosphonate therapy A systematic review of case/case series studies
Andrea Giusti et al.
BONE (2010)
Unusual mid-shaft fractures during long-term bisphosphonate therapy
Clarita V. Odvina et al.
CLINICAL ENDOCRINOLOGY (2010)
Case Reports: Subtrochanteric Femoral Stress Fractures after Prolonged Alendronate Therapy
Katerina Cermak et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2010)
Mineralization Density Distribution of Postmenopausal Osteoporotic Bone Is Restored to Normal After Long-Term Alendronate Treatment: qBEI and sSAXS Data From the Fracture Intervention Trial Long-Term Extension (FLEX)
P. Roschger et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Teriparatide for Acceleration of Fracture Repair in Humans: A Prospective, Randomized, Double-Blind Study of 102 Postmenopausal Women With Distal Radial Fractures
Per Aspenberg et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Efficacy of Continued Alendronate for Fractures in Women With and Without Prevalent Vertebral Fracture: The FLEX Trial
Ann V. Schwartz et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Prevention of Bone Loss by Zoledronic Acid in Premenopausal Women Undergoing Adjuvant Chemotherapy Persist up to One Year following Discontinuing Treatment
Dawn L. Hershman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Lack of Sustained Response to Teriparatide in a Patient with Adult Hypophosphatasia
Claudia Gagnon et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Femoral Cortical Stress Lesions in Long-Term Bisphosphonate Therapy: A Herald of Impending Fracture?
Joyce S. B. Koh et al.
JOURNAL OF ORTHOPAEDIC TRAUMA (2010)
Teriparatide May Accelerate Healing in Delayed Unions of Type III Odontoid Fractures A Report of 3 Cases
Paul T. Rubery et al.
JOURNAL OF SPINAL DISORDERS & TECHNIQUES (2010)
Evolving Data about Subtrochanteric Fractures and Bisphosphonates
Elizabeth Shane
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bisphosphonates and Fractures of the Subtrochanteric or Diaphyseal Femur
Dennis M. Black et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Atypical Femoral Fractures and Bisphosphonate Use
Christian M. Girgis et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Bisphosphonate-associated femoral fracture: implications for management in patients with malignancies
N. Napoli et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Successful treatment of sternal fracture nonunion with teriparatide
S. Chintamaneni et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Alendronate-related femoral diaphysis fracture-what should be done to predict and prevent subsequent fracture of the contralateral side?
M. H. Edwards et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Fragility fractures of the hip and femur: incidence and patient characteristics
J. W. Nieves et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2010)
Low-Energy Femoral Fractures Associated With Long-Term Bisphosphonate Use in a Rehabilitation Setting: A Case Series
Robert D. Bunning et al.
PM&R (2010)
Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate
Jorg Schilcher et al.
ACTA ORTHOPAEDICA (2009)
Spontaneous femoral shaft fracture after long-term alendronate
Tamir Ali et al.
AGE AND AGEING (2009)
Subtrochanteric stress fractures in six patients on long term bisphosphonate therapy: A case series
D. A. Glennon
BONE (2009)
Stress fracture healing: Fatigue loading of the rat ulna induces upregulation in expression of osteogenic and angiogenic genes that mimic the intramembranous portion of fracture repair
Gregory R. Wohl et al.
BONE (2009)
Bone Turnover in Bone Biopsies of Patients with Low-Energy Cortical Fractures Receiving Bisphosphonates: A Case Series
Reina Armamento-Villareal et al.
CALCIFIED TISSUE INTERNATIONAL (2009)
Case Reports: Two Femoral Insufficiency Fractures after Long-term Alendronate Therapy
Arkan S. Sayed-Noor et al.
CLINICAL ORTHOPAEDICS AND RELATED RESEARCH (2009)
Low-Energy Femoral Fractures Associated with the Long-Term Use of Bisphosphonates A Case Series from a Swiss University Hospital
Kuntheavy Ing-Lorenzini et al.
DRUG SAFETY (2009)
National data of 6409 Swedish inpatients with femoral shaft fractures: Stable incidence between 1998 and 2004
Rudiger J. Weiss et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2009)
Quality of life after a subtrochanteric fracture A prospective cohort study on 87 elderly patients
Wilhelmina Ekstrom et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2009)
Bilateral atypical femoral diaphyseal fractures in a patient treated with alendronate sodium
Joon Kiong Lee
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2009)
Bilateral Low-Energy Simultaneous or Sequential Femoral Fractures in Patients on Long-Term Alendronate Therapy
Craig M. Capeci et al.
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME (2009)
Bilateral Fractures of the Femur Diaphysis in a Patient With Rheumatoid Arthritis on Long-Term Treatment With Alendronate: Clues to the Mechanism of Increased Bone Fragility
Matthijs P. Somford et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Atypical Femoral Fractures, Bisphosphonates, and Adult Hypophosphatasia
Michael P. Whyte
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Subtrochanteric and Diaphyseal Femur Fractures in Patients Treated With Alendronate: A Register-Based National Cohort Study
Bo Abrahamsen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Recurrent Low-Energy Femoral Shaft Fractures and Osteonecrosis of the Jaw in a Case of Multiple Myeloma Treated With Bisphosphonates
Jonathan M. Grasko et al.
JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY (2009)
Effects of 1 to 3 Years' Treatment with Alendronate on Mechanical Properties of the Femoral Shaft in a Canine Model: Implications for Subtrochanteric Femoral Fracture Risk
David B. Burr et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2009)
Giant Osteoclast Formation and Long-Term Oral Bisphosphonate Therapy
Robert S. Weinstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Atraumatic Bilateral Femur Fracture in Long-Term Bisphosphonate Use
Maria S. Goddard et al.
ORTHOPEDICS (2009)
Changes in non-enzymatic glycation and its association with altered mechanical properties following 1-year treatment with risedronate or alendronate
S. Y. Tang et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study
B. A. Lenart et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Spectroscopic markers of bone quality in alendronate-treated postmenopausal women
A. L. Boskey et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Excess mortality following hip fracture: a systematic epidemiological review
B. Abrahamsen et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Subtrochanteric displaced insufficiency fracture after long-term alendronate therapy - a case report
Arkan S. Sayed-Noor et al.
ACTA ORTHOPAEDICA (2008)
Bone mineralization density distribution in health and disease
P. Roschger et al.
BONE (2008)
Alendronate reduces bone toughness of ribs without significantly increasing microdamage accumulation in dogs following 3 years of daily treatment
Matthew R. Allen et al.
CALCIFIED TISSUE INTERNATIONAL (2008)
Modulation of dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss
Feng-Sheng Wang et al.
ENDOCRINOLOGY (2008)
An emerging pattern of subtrochanteric stress fractures: A long-term complication of alendronate therapy?
Ernest Beng Kee Kwek et al.
INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED (2008)
Gender differences in epidemiology and outcome after hip fracture - Evidence from the Scottish hip fracture audit
G. Holt et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2008)
Connexin 43 Is Required for the Anti-Apoptotic Effect of Bisphosphonates on Osteocytes and Osteoblasts In Vivo
Lilian I. Plotkin et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Effect of Temporal Changes in Bone Turnover on the Bone Mineralization Density Distribution: A Computer Simulation Study
Davide Ruffoni et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Severely suppressed bone turnover and atypical skeletal fragility
Maja Visekruna et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Low-energy femoral shaft fractures associated with alendronate use
Andrew S. Neviaser et al.
JOURNAL OF ORTHOPAEDIC TRAUMA (2008)
The association of race, gender, and comorbidity with mortality and function after hip fracture
Joan D. Penrod et al.
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES (2008)
Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate
Brett A. Lenart et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Collagen maturity, glycation induced-pentosidine, and mineralization are increased following 3-year treatment with incadronate in dogs
M. Saito et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Prevention of corticosteroid-induced osteonecrosis in rabbits by intra-bone marrow injection of autologous bone marrow cells
T. Asada et al.
RHEUMATOLOGY (2008)
Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra
M. R. Allen et al.
OSTEOPOROSIS INTERNATIONAL (2008)
Effects of intravenous zoledronic acid once yearly on bone remodeling and bone structure
Robert R. Recker et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Low-intensity pulsed ultrasound and nonsteroidal anti-inflammatory drugs have opposing effects during stress fracture repair
Jiliang Li et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2007)
Three years of alendronate treatment results in similar levels of vertebral microdamage as after one year of treatment
Matthew R. Allen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Skeletal self-repair: Stress fracture healing by rapid formation and Densification of woven bone
Brian A. Uthgenannt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Quantifying osteoblast and osteocyte apoptosis: Challenges and rewards
Robert L. Jilka et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Microcrack frequency and bone remodeling in postmenopausal osteoporotic women on long-term bisphosphonates: A bone biopsy study
Roland D. Chapurlat et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Low bone mineral density is associated with bone microdamage accumulation in postmenopausal women with osteoporosis
Jan J. Stepan et al.
BONE (2007)
Bilateral femoral insuffiency fractures treated with inflatable intramedullary nails: a case report
Bahtiyar Demiralp et al.
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY (2007)
Effect of short-term treatment with alendronate on ulnar bone adaptation to cyclic fatigue loading in rats
Jennifer G. Barrett et al.
JOURNAL OF ORTHOPAEDIC RESEARCH (2007)
Looking beyond low bone mineral density: Multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy
P. Lee et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2007)
Stress fractures in the lower extremity - The importance of increasing awareness amongst radiologists
Ferco H. Berger et al.
EUROPEAN JOURNAL OF RADIOLOGY (2007)
Effects of non-enzymatic glycation on cancellous bone fragility
S. Y. Tang et al.
BONE (2007)
Subtrochanteric insufficiency fractures in patients on alendronate therapy - A caution
S.-K. Goh et al.
JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME (2007)
Effects of continuing or stopping alendronate after 5 years of treatment - The Fracture Intervention Trial long-term extension (FLEX): A randomized trial
Dennis M. Black et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Exercise distance and speed affect the risk of fracture in racehorses
Kristien Verheyen et al.
BONE (2006)
Suppressed bone turnover during alendronate therapy for high-turnover osteoporosis
Reina Armamento-Villareal et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Contribution of the advanced glycation end product pentosidine and of maturation of type I collagen to compressive biomechanical properties of human lumbar vertebrae
S. Viguet-Carrin et al.
BONE (2006)
Raloxifene enhances vertebral mechanical properties independent of bone density
Matthew R. Allen et al.
BONE (2006)
Bone material properties in trabecular bone from human iliac crest biopsies after 3-and 5-year treatment with risedronate
Erich Durchschlag et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Alterations in canine vertebral bone turnover, microdamage accumulation, and biomechanical properties following 1-year treatment with clinical treatment doses of risedronate or alendronate
Matthew R. Allen et al.
BONE (2006)
Long-term risedronate treatment normalizes mineralization and continues to preserve trabecular architecture: Sequential triple biopsy studies with micro-computed tomography
B Borah et al.
BONE (2006)
Effects of 3-and 5-year treatment with risedronate on bone mineralization density distribution in triple biopsies of the iliac crest in postmenopausal women
Ruth Zoehrer et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Stress fractures of the femoral shaft in athletes: a new treatment algorithm
A. Ivkovic et al.
BRITISH JOURNAL OF SPORTS MEDICINE (2006)
Novel insights into actions of bisphosphonates on bone: Differences in interactions with hydroxyapatite
G. H. Nancollas et al.
BONE (2006)
Discontinuing antiresorptive therapy one year after cardiac transplantation: Effect on bone density and bone turnover
A Cohen et al.
TRANSPLANTATION (2006)
Microcrack initiattion occurs more easily in vertebrae from beagles treated with alendronate than with risedronate
K Iwata et al.
BONE (2006)
Imaging bone microdamage in vivo with positron emission tomography
JL Li et al.
BONE (2005)
Trabecular microfracture and the influence of pyridinium and non-enzymatic glycation-mediated collagen cross-links
CJ Hernandez et al.
BONE (2005)
Incidence of hip fracture in Shiraz, Iran
M Soveid et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters
M Arlot et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
CT and MR imaging findings in athletes with early tibial stress injuries: Comparison with bone scintigraphy findings and emphasis on cortical abnormalities
M Gaeta et al.
RADIOLOGY (2005)
Severely suppressed bone turnover: A potential complication of alendronate therapy
CV Odvina et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Human femoral neck has less cellular periosteum, and more mineralized periosteum, than femoral diaphyseal bone
MR Allen et al.
BONE (2005)
The effect of prophylactic treatment with risedronate on stress fracture incidence among infantry recruits
C Milgrom et al.
BONE (2004)
Seven years of treatment with risedronate in women with postmenopausal osteoporosis
DD Mellström et al.
CALCIFIED TISSUE INTERNATIONAL (2004)
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture
O Johnell et al.
OSTEOPOROSIS INTERNATIONAL (2004)
Alendronate has a residual effect on bone mass in postmenopausal Danish women up to 7 years after treatment withdrawal
YZ Bagger et al.
BONE (2003)
Constant mineralization density distribution in cancellous human bone
P Roschger et al.
BONE (2003)
Long-term efficacy of risedronate: a 5-year placebo-controlled clinical experience
OH Sorensen et al.
BONE (2003)
Raloxifene, estrogen, and alendronate affect the processes of fracture repair differently in ovariectomized rats
YP Cao et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Effects of long-term risedronate on bone quality and bone turnover in women with postmenopausal osteoporosis
EF Eriksen et al.
BONE (2002)
Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid
J Wood et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Age-related changes in the collagen network and toughness of bone
X Wang et al.
BONE (2002)
Dissociation of angiogenesis and osteoclastogenesis during endochondral bone formation in neonatal mice
MML Deckers et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Targeted and nontargeted bone remodeling: relationship to basic multicellular unit origination and progression
AM Parfitt
BONE (2002)
Imaging of stress fractures in the athlete
DJ Spitz et al.
RADIOLOGIC CLINICS OF NORTH AMERICA (2002)
Bisphosphonate treatment suppresses not only stochastic remodeling but also the targeted repair of microdamage
J Li et al.
CALCIFIED TISSUE INTERNATIONAL (2001)
Alendronate increases degree and uniformity of mineralization in cancellous bone and decreases the porosity in cortical bone of osteoporotic women
P Roschger et al.
BONE (2001)
Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles
T Mashiba et al.
BONE (2001)
Influence of nonenzymatic glycation on biomechanical properties of cortical bone
D Vashishth et al.
BONE (2001)
Effects of alendronate on bone quality and remodeling in glucocorticoid-induced osteoporosis: A histomorphometric analysis of transiliac biopsies
PM Chavassieux et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Suppressed bone turnover by bisphosphonates increases microdamage accumulation and reduces some biomechanical properties in dog rib
T Mashiba et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2000)
Alendronate increases bone strength by increasing the mean degree of mineralization of bone tissue in osteoporotic women
GY Boivin et al.
BONE (2000)
Share Paper
